141 related articles for article (PubMed ID: 9680929)
21. Relevance of specific immunoglobulin M and immunoglobulin G for parvovirus B19 diagnosis in patients with acute lymphoblastic leukemia receiving chemotherapy: prospective study.
el-Sayed Zaki M
Arch Pathol Lab Med; 2007 Nov; 131(11):1697-9. PubMed ID: 17979489
[TBL] [Abstract][Full Text] [Related]
22. Clinical and hematological study for Parvovirus b19 infection in children with acute leukemia.
Zaki ME; Ashray RE
Int J Lab Hematol; 2010 Apr; 32(2):159-66. PubMed ID: 19261033
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and genotypic characterization of Human Parvovirus B19 in children with measles- and rubella-like illness in Iran.
Rezaei F; Sarshari B; Ghavami N; Meysami P; Shadab A; Salimi H; Mokhtari-Azad T
J Med Virol; 2016 Jun; 88(6):947-53. PubMed ID: 26538067
[TBL] [Abstract][Full Text] [Related]
24. Occurrence and clinical role of active parvovirus B19 infection in transplant recipients.
Gallinella G; Manaresi E; Venturoli S; Grazi GL; Musiani M; Zerbini M
Eur J Clin Microbiol Infect Dis; 1999 Nov; 18(11):811-3. PubMed ID: 10614957
[TBL] [Abstract][Full Text] [Related]
25. Parvovirus B19 infection in pediatric oncology patients: diagnostic value of clinical and serologic parameters compared with nested PCR.
Soliman Oel-S; Abd El-Aal Hegazi Hasan M; El-Ashry R; Zaghloul MH; Kora B
J Pediatr Hematol Oncol; 2009 Mar; 31(3):173-6. PubMed ID: 19262242
[TBL] [Abstract][Full Text] [Related]
26. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection.
Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S
Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688
[TBL] [Abstract][Full Text] [Related]
27. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura.
Heegaard ED; Rosthøj S; Petersen BL; Nielsen S; Karup Pedersen F; Hornsleth A
Acta Paediatr; 1999 Jun; 88(6):614-7. PubMed ID: 10419244
[TBL] [Abstract][Full Text] [Related]
28. Genotype 3b of human parvovirus B19 detected from hospitalized children with solid malignancies in a North Indian tertiary care hospital.
Jain A; Jain P; Prakash S; Kumar A; Khan DN; Seth A; Gupta S; Kant R
J Med Virol; 2016 Nov; 88(11):1922-9. PubMed ID: 27116539
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of parvovirus B19-specific antibodies and of viral DNA in patients with endogenous uveitis.
Heinz C; Plentz A; Bauer D; Heiligenhaus A; Modrow S
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):999-1004. PubMed ID: 15906067
[TBL] [Abstract][Full Text] [Related]
30. The role of parvovirus B19 infection in childhood acute lymphoblastic leukemia.
Heegaard ED; Jensen L; Hornsleth A; Schmiegelow K
Pediatr Hematol Oncol; 1999; 16(4):329-34. PubMed ID: 10407869
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and genotypic characterization of human parvovirus B19 in children with hemato-oncological disorders in North India.
Jain P; Jain A; Prakash S; Khan DN; Singh DD; Kumar A; Moulik NR; Chandra T
J Med Virol; 2015 Feb; 87(2):303-9. PubMed ID: 25087946
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 infection in children with a variety of hematological disorders.
Zaki Mel S; Hassan SA; Seleim T; Lateef RA
Hematology; 2006 Aug; 11(4):261-6. PubMed ID: 17178665
[TBL] [Abstract][Full Text] [Related]
34. Transient erythroblastopenia of childhood: prospective study of 10 patients with special reference to viral infections.
Skeppner G; Kreuger A; Elinder G
J Pediatr Hematol Oncol; 2002 May; 24(4):294-8. PubMed ID: 11972099
[TBL] [Abstract][Full Text] [Related]
35. Evidence for persistence of parvovirus B19 DNA in livers of adults.
Eis-Hübinger AM; Reber U; Abdul-Nour T; Glatzel U; Lauschke H; Pütz U
J Med Virol; 2001 Oct; 65(2):395-401. PubMed ID: 11536250
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.
Zadsar M; Aghakhani A; Banifazl M; Kazemimanesh M; Tabatabaei Yazdi SM; Mamishi S; Bavand A; Sadat Larijani M; Ramezani A
J Med Virol; 2018 Aug; 90(8):1318-1322. PubMed ID: 29663448
[TBL] [Abstract][Full Text] [Related]
37. Parvovirus B19 infection in children with acute illness and rash.
Pruksachatkunakorn C; Apichartpiyakul N; Kanjanaratanakorn K
Pediatr Dermatol; 2006; 23(3):216-8. PubMed ID: 16780465
[TBL] [Abstract][Full Text] [Related]
38. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
39. Persistence of parvovirus B19 DNA in synovium of patients with haemophilic arthritis.
Zakrzewska K; Azzi A; De Biasi E; Radossi P; De Santis R; Davoli PG; Tagariello G
J Med Virol; 2001 Oct; 65(2):402-7. PubMed ID: 11536251
[TBL] [Abstract][Full Text] [Related]
40. Detection of human parvovirus B19 in cancer patients using ELISA and real-time PCR.
Zaki SA
Indian J Med Microbiol; 2012; 30(4):407-10. PubMed ID: 23183464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
